2020
DOI: 10.1016/j.mpaic.2020.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Malignant hyperthermia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(15 citation statements)
references
References 4 publications
0
10
0
5
Order By: Relevance
“…Hyperkalemia was noted in our patient on the afternoon of postoperative day 1. Although the literature describes case reports with contradictory serum potassium concentration, reviews of MH specify that hyperkalemia is indicative of MH crisis triggering [1,3,7,8,12,17]. According to Mahmood (2018) [40], hyperkalemia can induce fatal cardiac dysrhythmias.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Hyperkalemia was noted in our patient on the afternoon of postoperative day 1. Although the literature describes case reports with contradictory serum potassium concentration, reviews of MH specify that hyperkalemia is indicative of MH crisis triggering [1,3,7,8,12,17]. According to Mahmood (2018) [40], hyperkalemia can induce fatal cardiac dysrhythmias.…”
Section: Discussionmentioning
confidence: 99%
“…Malignant hyperthermia (MH) is an acute pharmacogenetic disorder, which while uncommon is potentially fatal [1,2]. In humans, susceptibility to MH is an inherited disorder and it has an autosomal dominant pattern [3][4][5][6][7]. To date, genes located at six chromosomal loci associated with MH have been described: 1) Ryanodine receptor type 1 (RyR1) gene, ryanodine receptor found in skeletal muscle (chromosomal locus 19q13.1.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations